BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30668178)

  • 1. Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor?
    Miyamoto T; Shiozawa T
    Gynecol Endocrinol; 2019 May; 35(5):370-375. PubMed ID: 30668178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and insulin synergistically promote type 1 endometrial cancer progression.
    Tian W; Teng F; Zhao J; Gao J; Gao C; Sun D; Liu G; Zhang Y; Yu S; Zhang W; Wang Y; Xue F
    Cancer Biol Ther; 2017 Dec; 18(12):1000-1010. PubMed ID: 29172956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells.
    Miyamoto T; Shiozawa T; Kashima H; Feng YZ; Suzuki A; Kurai M; Nikaido T; Konishi I
    Endocrinology; 2006 Oct; 147(10):4863-70. PubMed ID: 16825317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-sex cord-stromal ovarian tumors frequently produce and secrete estrogen in postmenopausal women: impact on bone metabolism and abnormal endometrial histology.
    Matsumura S; Ohta T; Takahashi T; Yamazaki T; Takahashi K; Kurachi H
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2775-82. PubMed ID: 23780377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
    Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
    Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and endometrial carcinogenesis.
    Kamal A; Tempest N; Parkes C; Alnafakh R; Makrydima S; Adishesh M; Hapangama DK
    Horm Mol Biol Clin Investig; 2016 Feb; 25(2):129-48. PubMed ID: 26966933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients.
    Berstein LM; Bakhidze EV; Evtushenko TP; Gamajunova VB; Krjukova OG; Kovalenko IG; Tsyrlina EV; Bokhman JaV
    Mutat Res; 1996 Sep; 356(2):203-8. PubMed ID: 8841486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endometrium--from estrogens alone to TSECs.
    Pickar JH
    Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and Growth Regulation of Epithelial and Stromal Cells From the Normal and Malignant Endometrium by Pigment Epithelium-Derived Factor.
    Daubriac J; Pandya UM; Huang KT; Pavlides SC; Gama P; Blank SV; Shukla P; Crawford SE; Gold LI
    Endocrinology; 2017 Sep; 158(9):2754-2773. PubMed ID: 28911166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways.
    Lépine J; Audet-Walsh E; Grégoire J; Têtu B; Plante M; Ménard V; Ayotte P; Brisson J; Caron P; Villeneuve L; Bélanger A; Guillemette C
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2689-98. PubMed ID: 20371658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIZ1 is regulated by estrogen and suppresses tumor progression in endometrial cancer.
    Yang T; Ren C; Jiang A; Yu Z; Li G; Wang G; Zhang Q
    Biochem Biophys Res Commun; 2017 Jul; 489(2):96-102. PubMed ID: 28528974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
    Banno K; Yanokura M; Iida M; Masuda K; Aoki D
    J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endometrium: effects of estrogen and estrogen-progestogen replacement therapy.
    Samsioe G
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():84-92. PubMed ID: 7874191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear type II estradiol binding sites and type I estrogen receptors in human endometrial cancer: a 5-year follow-up study.
    Környei JL; Csermely T; Keller G; Vértes M
    Gynecol Oncol; 1993 Jan; 48(1):94-103. PubMed ID: 8423028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
    Taylor AH; al-Azzawi F; Pringle JH; Bell SC
    Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.
    Ito K
    Tohoku J Exp Med; 2007 May; 212(1):1-12. PubMed ID: 17464097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology.
    Wasniewski T; Woclawek-Potocka I
    Gynecol Endocrinol; 2018 May; 34(5):422-427. PubMed ID: 29182028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
    Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.